147 related articles for article (PubMed ID: 8362984)
1. Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease.
Kalaria RN; Golde T; Kroon SN; Perry G
Am J Pathol; 1993 Sep; 143(3):886-93. PubMed ID: 8362984
[TBL] [Abstract][Full Text] [Related]
2. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
[TBL] [Abstract][Full Text] [Related]
3. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
5. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
7. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
Kalaria RN; Galloway PG; Perry G
Neuropathol Appl Neurobiol; 1991 Jun; 17(3):189-201. PubMed ID: 1891063
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
Gómez-Ramos P; Mufson EJ; Morán MA
Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
[TBL] [Abstract][Full Text] [Related]
9. Identification of septins in neurofibrillary tangles in Alzheimer's disease.
Kinoshita A; Kinoshita M; Akiyama H; Tomimoto H; Akiguchi I; Kumar S; Noda M; Kimura J
Am J Pathol; 1998 Nov; 153(5):1551-60. PubMed ID: 9811347
[TBL] [Abstract][Full Text] [Related]
10. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
[TBL] [Abstract][Full Text] [Related]
12. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
Muramori F; Kobayashi K; Nakamura I
Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
[TBL] [Abstract][Full Text] [Related]
13. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.
Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K
Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
15. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
Culpan D; Cram D; Chalmers K; Cornish A; Palmer L; Palmer J; Hughes A; Passmore P; Craig D; Wilcock GK; Kehoe PG; Love S
Neurobiol Aging; 2009 Jul; 30(7):1052-60. PubMed ID: 18069092
[TBL] [Abstract][Full Text] [Related]
16. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease.
Snow AD; Mar H; Nochlin D; Kresse H; Wight TN
J Histochem Cytochem; 1992 Jan; 40(1):105-13. PubMed ID: 1370306
[TBL] [Abstract][Full Text] [Related]
17. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
Ho GJ; Hashimoto M; Adame A; Izu M; Alford MF; Thal LJ; Hansen LA; Masliah E
Neurobiol Aging; 2005 May; 26(5):625-35. PubMed ID: 15708437
[TBL] [Abstract][Full Text] [Related]
18. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
Hyman BT; Elvhage TE; Reiter J
Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
Molho-Sabatier P; Aiach M; Gaillard I; Fiessinger JN; Fischer AM; Chadeuf G; Clauser E
J Clin Invest; 1989 Oct; 84(4):1236-42. PubMed ID: 2794060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
